Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Investing

Another Study Shows Nicotine E-Cigarettes Help Smokers to Quit

by June 17, 2024
June 17, 2024
Another Study Shows Nicotine E-Cigarettes Help Smokers to Quit

Jeffrey A. Singer

Finnish researchers published the results of a randomized controlled trial in today’s JAMA Internal Medicine, comparing varenicline (Chantix) to nicotine e‑cigarettes in helping tobacco smokers quit smoking. The researchers concluded, “This randomized clinical trial found that varenicline and nicotine‐​containing ECs were both effective in helping individuals in quitting smoking conventional cigarettes for up to 6 months.”

Varenicline works on receptor sites in the brain to reduce the craving for and satisfaction with nicotine. The Food and Drug Administration denies tobacco smokers wishing to quit access to varenicline unless they get a permission slip (prescription) from a government‐​approved gatekeeper (usually a physician, nurse practitioner, or physician assistant). However, as of 2022, eight states allow pharmacists to prescribe varenicline, sparing smokers the expense in time and money of a visit to the doctor’s office to get a prescription.

This is a significant study because most studies compare varenicline to placebo or e‑cigarettes to placebo. However, this was a high‐​quality comparative effectiveness study. The study was randomized and placebo‐​based, and the participants, study nurses, and researchers were all masked as to group assignment. One group received nicotine e‑cigarettes plus placebo tablets; another group received varenicline and an e‑cigarette that did not contain nicotine; the third group received a nicotine‐​free e‑cigarette and a placebo tablet.

The group of 458 adults (age range 25–75) were given these treatments, along with tobacco cessation counseling, for twelve weeks. After twenty‐​six weeks, the researchers assessed the participants’ quit rates. They found no statistically significant difference between the quit rates of those on varenicline alone vs those on nicotine e‑cigarettes alone (43.8 percent and 40.4 percent, respectively).

In the UK, the National Health Service considers nicotine relatively harmless, considers nicotine e‑cigarettes to be an effective tobacco cessation strategy, and encourages primary care practitioners to suggest it to their patients who smoke. Australia, on the other hand, highly regulates nicotine e‑cigarettes, tightly restricts their supply, and requires people to get a doctor’s prescription for them. Unfortunately, very few Australian doctors will prescribe it, and even if adults who want to quit are fortunate enough to get a doctor’s permission slip, most pharmacies don’t stock them. Australia now has a black market and the associated violent crime one would expect to see with such prohibition.

This study vindicates the NHS’s position regarding e‑cigarettes.

Meanwhile, as the FDA continues its painfully slow process of deciding which e‑cigarettes American adults will be free to buy, and as some politicians wage war on nicotine products, a black market in illicit e‑cigarettes grows.

0
FacebookTwitterGoogle +Pinterest
previous post
Gold Top? Focus on These Potential Price Objectives
next post
It’s TOO EARLY to Be Bullish on Tesla

You may also like

The New Deal and Recovery, Part 28: A...

April 12, 2023

A Case Study in Tax Credit Fraud and...

May 2, 2024

The Right to Control Your Property Is Fundamental

April 11, 2025

The Fifth Amendment is Self‐​Executing

May 17, 2023

The Biden Administration Continues to Be Wrong about...

September 26, 2023

Signs of the Bright Future for Local News

November 28, 2023

Maine Legalizes the Sale of Prostitution Services

July 3, 2023

Speech Codes and Commissions Trample on the Expressive...

May 30, 2024

Border Patrol Agent Deaths in the Line of...

January 8, 2024

Biden Bows Out from 2024 Race

July 22, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Gladney Darroh: Building a Career on Grit, Service, and Second Chances

      August 23, 2025
    • Cracker Barrel CEO serves up leftover corporate branding to unhappy customers

      August 23, 2025
    • How Hertz’s EV Road Trip Planner takes the stress out of electric journeys

      August 23, 2025
    • Best Clip-In Hair Extensions UK 2025: Top 10 Brands for Autumn Transformations

      August 23, 2025
    • GOP senators push Kamala Harris testimony as House Oversight eyes subpoena

      August 23, 2025
    • Mitchell Geisler on Listening, Leadership and Business Growth

      August 23, 2025

    Categories

    • Business (8,861)
    • Investing (2,235)
    • Politics (16,467)
    • Stocks (3,228)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved